anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Source Note

Component collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 110,355
Current window 47,521-47,550
Pages 3,679
Rows per page 30
Component: Source Noteclear collectionreset all
18 30 60

Component

47,521-47,550 of 110,355

filter-aware
407
The slide presents a summary of an expert interview, highlighting the endocrinologist's preference for GLP-1s over Vykat for PWS patients.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
408
The slide uses direct quotes from an endocrinologist to frame potential medical risks as a barrier to adoption.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
409
The slide uses direct quotes to build a narrative of expert doubt.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
410
The slide uses Q&A transcripts to highlight the expert's skepticism regarding Vykat's value proposition.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
411
The slide uses a Q&A format to highlight the administrative burden and slow approval process for the drug Vykat.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
412
The slide uses a Q&A transcript format to validate the claim of trial unblinding.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
413
The slide uses a Q&A format to present primary research findings from a consultation call.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
414
The slide uses Q&A transcript format to build credibility for the thesis that generic substitution is common practice among specialists.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
415
Includes a Q&A transcript snippet highlighting anecdotal evidence.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
11
The slide uses extreme, inflammatory language to attack the subject company and its leadership.TransMedics (TMDX) · Scorpion Capital
Research note Short seller Beat · Critique of TransMedics Group Inc.1 hit
12
The slide uses a 'Spy The Lie' framework to interpret CEO responses as deceptive.TransMedics (TMDX) · Scorpion Capital
Research note Short seller Beat · Critique of TransMedics Group Inc.1 hit
13
The slide uses aggressive, accusatory language ('fraud', 'hubris', 'one-trick pony') to frame the company negatively.TransMedics (TMDX) · Scorpion Capital
Research note Short seller Beat · Critique of TransMedics Group Inc.1 hit
14
The slide uses a 'villain' narrative to frame the CEO's actions as potentially criminal, leveraging a recent legal precedent to build credibility.TransMedics (TMDX) · Scorpion Capital
Research note Short seller Beat · Critique of TransMedics Group Inc.1 hit
15
The slide uses a short-selling thesis style, highlighting valuation concerns and legal/regulatory risks in the medical air transport industry.TransMedics (TMDX) · Scorpion Capital
Research note Short seller Beat · Critique of TransMedics Group Inc.1 hit
16
The slide uses a 'wink-wink' narrative to frame the company's own marketing as evidence of a non-clinical value proposition.TransMedics (TMDX) · Scorpion Capital
Research note Short seller Beat · Critique of TransMedics Group Inc.1 hit
17
The slide uses highly charged, aggressive language to frame the company and its leadership as predatory and unprofessional.TransMedics (TMDX) · Scorpion Capital
Research note Short seller Beat · Critique of TransMedics Group Inc.1 hit
18
The slide uses direct quotes to build a narrative of customer churn risk, specifically highlighting the threat of switching to OrganOX.TransMedics (TMDX) · Scorpion Capital
Research note Short seller Beat · Critique of TransMedics Group Inc.1 hit
19
The slide uses a combination of narrative summary and a direct Q&A transcript excerpt to substantiate claims of unethical conduct.TransMedics (TMDX) · Scorpion Capital
Research note Short seller Beat · Critique of TransMedics Group Inc.1 hit
20
The slide uses strong, emotive language ('greedy', 'predatory', 'hate') to frame the company as a villain in the transplant market.TransMedics (TMDX) · Scorpion Capital
Research note Short seller Beat · Critique of TransMedics Group Inc.1 hit
21
The slide uses a combination of narrative analysis and direct testimonial quotes to build a bearish case against the company.TransMedics (TMDX) · Scorpion Capital
Research note Short seller Beat · Exposure of Contradictions1 hit
22
The slide uses aggressive, short-selling style language ('colossal failure', 'crashing and burning', 'one-trick pony').TransMedics (TMDX) · Scorpion Capital
Research note Short seller Beat · Exposure of Contradictions1 hit
23
The slide uses a sarcastic tone to undermine the company's intellectual property claims.TransMedics (TMDX) · Scorpion Capital
Research note Short seller Beat · Exposure of Contradictions1 hit
24
The slide uses a 'villain' framing to attack the company's business model as exploitative of the US healthcare system.TransMedics (TMDX) · Scorpion Capital
Research note Short seller Beat · Exposure of Contradictions1 hit
25
The slide uses a 'villain critique' approach to frame the company's business model as a 'government pay scam'.TransMedics (TMDX) · Scorpion Capital
Research note Short seller Beat · Exposure of Contradictions1 hit
26
Uses direct quotes from industry experts to build a case of systemic exploitation.TransMedics (TMDX) · Scorpion Capital
Research note Short seller Beat · Exposure of Contradictions1 hit
27
The slide uses a combination of investigative journalism style text and corporate marketing materials to expose a perceived conflict of interest.TransMedics (TMDX) · Scorpion Capital
Research note Short seller Beat · Exposure of Contradictions1 hit
28
The slide uses a combination of anecdotal evidence from centers and financial logic to frame the company's business model as fraudulent.TransMedics (TMDX) · Scorpion Capital
Research note Short seller Beat · Exposure of Contradictions1 hit
29
The slide uses a Q&A format to highlight specific allegations from an industry executive regarding OIG, DOJ, and IRS involvement.TransMedics (TMDX) · Scorpion Capital
Research note Short seller Beat · Exposure of Contradictions1 hit
30
The slide uses highlighted text to emphasize key quotes from an industry executive regarding systemic abuse of the cost-based reimbursement model.TransMedics (TMDX) · Scorpion Capital
Research note Short seller Beat · Exposure of Contradictions1 hit
31
The slide uses direct quotes from an industry executive to build a bearish case against TransMedics.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit